Joslin Diabetes Center
Boston, Massachusetts, 02215, United States
NCT Number: NCT00142922
Performance of self-care recommendations is key to the successful treatment of diabetes. However, many patients have difficulty adhering to diabetes self-care recommendations. Recent results from our own studies and others have identified specific barriers to diabetes self-care. To evaluate the efficacy of a diabetes educator-led group intervention, the Breaking Down Barriers Program, that addresses barriers and therefore leads to improved adherence to diabetes self-care recommendations, we will randomize 222 (111 type 1 and 111 type 2) diabetes patients to one of three conditions: 1) the Breaking Down Barriers Program, 2) a cholesterol attention control condition, or 3) a 'usual care' control condition. We hypothesize that those assigned to the Breaking Down Barriers group will improve self-care behaviors and glycemic control more than those in the two control groups. We will follow study subjects for one year to determine whether their self-care behaviors and glycemic control improved and if the improvement was maintained over time.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02215, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For Patients With Type 1 Diabetes
For Patients With Type 2 Diabetes
Exclusion criteria
completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229718
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT07403565
Autoimmune Diseases, Diabetes Mellitus
Beijing, Beijing Municipality, China
View Trial DetailsNCT05253521
Autoimmune Diseases, Brain Diseases
Markham, Ontario, Canada
View Trial DetailsNCT04698122
Autoimmune Diseases, Diabetes Mellitus
Perugia, Italy
View Trial Details